Specialized Oncology CRO Theradex Oncology’s focus on full-service clinical research for all indications and modalities, combined with over 40 years of experience, positions it as a trusted partner for biotech and pharma companies seeking comprehensive trial solutions in oncology and emerging therapies.

Mid-sized Market Presence With a revenue estimate between 100 million and 250 million and a team of 51 to 200 employees, Theradex offers personalized, nimble service that can appeal to emerging biotech firms and mid-tier pharmaceutical companies looking for flexible CRO partnerships.

Broad Industry Expertise Theradex’s experience with data management, monitoring, and collaboration with the National Cancer Institute demonstrates versatility and established credibility, making it a reliable choice for clients seeking specialized oncology trial expertise.

Technology Infrastructure Utilizing advanced cloud and web technologies such as Google Cloud, Nginx, and PHP, Theradex demonstrates a commitment to modern, efficient data handling and trial management, which can enhance client confidence in their technological capability.

Partnership Opportunities Given its niche focus and long-standing industry experience, Theradex presents opportunities for strategic collaborations with emerging biotech firms seeking experienced CRO services tailored to oncology and rare indications, expanding its market reach.